Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Perioral Dermatitis

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Perioral Dermatitis

Leila Tolaymat et al.
Free Books & Documents

Excerpt

Perioral dermatitis is a benign eruption that occurs most commonly in young, female adults, consisting of small inflammatory papules and pustules or pink, scaly patches around the mouth. Although the perioral region is the most common distribution area, this disease can also affect the periocular and paranasal skin (see Image. Perioral Dermatitis). For this reason, this dermatologic phenomenon is often referred to as periorificial dermatitis.

A strong association exists between perioral dermatitis and topical corticosteroid use, particularly on the face. Initially responsive to steroids, the condition often worsens with withdrawal, potentially leading to chronic, recurrent disease or a granulomatous variant. Other potential triggers include inhaled or nasal corticosteroids, fluorinated toothpaste, chewing gum, dental materials, cosmetics, sunscreens, facemask use, and improper CPAP therapy. Hormonal factors may also play a role.

Diagnosis of perioral dermatitis is typically clinical, but biopsy or additional testing may be warranted in atypical cases. Despite existing guidelines, clinicians often misdiagnose perioral dermatitis and inappropriately prescribe topical corticosteroids, which worsen the condition over time. Therefore, recognizing steroid-induced flares is essential to reduce iatrogenic harm and ensure effective management.

Topical steroid use on the face can trigger perioral dermatitis, and therefore, a primary recommendation for treatment is the discontinuation of steroid application by the patient. However, Abrupt cessation of corticosteroids can cause rebound flaring; therefore, a gradual taper may be necessary. Other treatment approaches include topical metronidazole, topical calcineurin inhibitors, and oral tetracycline antibiotics. While treatment is generally effective, perioral dermatitis can be persistent or recurrent, requiring long-term management strategies tailored to the individual.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Leila Tolaymat declares no relevant financial relationships with ineligible companies.

Disclosure: Hasnain Syed declares no relevant financial relationships with ineligible companies.

Disclosure: Matthew Hall declares no relevant financial relationships with ineligible companies.

References

    1. Kosari P, Feldman SR. Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis. Dermatol Online J. 2009 Mar 15;15(3):15. - PubMed
    1. Ljubojeviae S, Basta-Juzbasiae A, Lipozenèiae J. Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol. 2002 Mar;16(2):121-6. - PubMed
    1. Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006 Jan;54(1):1-15; quiz 16-8. - PubMed
    1. Peralta L, Morais P. Perioral dermatitis -- the role of nasal steroids. Cutan Ocul Toxicol. 2012 Jun;31(2):160-3. - PubMed
    1. Poulos GA, Brodell RT. Perioral dermatitis associated with an inhaled corticosteroid. Arch Dermatol. 2007 Nov;143(11):1460. - PubMed

Publication types

LinkOut - more resources